{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:42:39Z","timestamp":1769506959576,"version":"3.49.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Sarcomas arising in the skin are rare but potentially fatal. These tumours originate from mesenchymal cells and can be divided between those that arise in soft tissue and those arising from bone. General guidelines exist for the management of soft-tissue sarcomas; however, there are no specific guidelines for cutaneous sarcomas. Current literature was reviewed for management of seven cutaneous sarcomas including atypical fibroxanthoma, pleomorphic dermal sarcoma, dermal and subcutaneous leiomyosarcoma, dermatofibroma sarcoma protuberans, Kaposi sarcoma, cutaneous angiosarcoma and malignant peripheral nerve sheath tumour. All suspected sarcomas should be discussed in a sarcoma multidisciplinary team meeting. This article is not a clinical guideline but should serve as a practical summary of how these tumours present, how they are recognized histologically, and how best to manage and follow-up patients. The aim is to support clinicians and facilitate the best and most evidence-based standard of care available.<\/jats:p>","DOI":"10.1093\/ced\/llad166","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T04:14:23Z","timestamp":1683000863000},"page":"866-872","source":"Crossref","is-referenced-by-count":7,"title":["Cutaneous sarcoma: a review and practical approach to\u00a0management"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3223-6040","authenticated-orcid":false,"given":"Sophie","family":"Stoneham","sequence":"first","affiliation":[{"name":"Department of Dermatology, St Mary's Hospital, Portsmouth Hospitals University NHS Trust , Portsmouth , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alys","family":"Hunter","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St Mary's Hospital, Portsmouth Hospitals University NHS Trust , Portsmouth , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-6585","authenticated-orcid":false,"given":"Mina","family":"Raahimi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St Mary's Hospital, Portsmouth Hospitals University NHS Trust , Portsmouth , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Livesey","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St Mary's Hospital, Portsmouth Hospitals University NHS Trust , Portsmouth , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles D","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St Mary's Hospital, Portsmouth Hospitals University NHS Trust , Portsmouth , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Keohane","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St Mary's Hospital, Portsmouth Hospitals University NHS Trust , Portsmouth , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"2024040918141071200_llad166-B1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13569-016-0060-4","article-title":"UK guidelines for the management of soft tissue sarcomas","volume":"6","author":"Dangoor","year":"2016","journal-title":"Clin Sarcoma Res"},{"key":"2024040918141071200_llad166-B2","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3","article-title":"Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group","volume":"91","author":"Coindre","year":"2001","journal-title":"Cancer"},{"key":"2024040918141071200_llad166-B3","doi-asserted-by":"crossref","first-page":"21763","DOI":"10.18632\/oncotarget.7845","article-title":"Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas","volume":"7","author":"Helbig","year":"2016","journal-title":"Oncotarget"},{"key":"2024040918141071200_llad166-B4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.det.2019.02.001","article-title":"Atypical fibroxanthoma and pleomorphic dermal sarcoma: updates on classification and management","volume":"37","author":"Soleymani","year":"2019","journal-title":"Dermatol Clin"},{"key":"2024040918141071200_llad166-B5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaad.2021.09.036","article-title":"Surgical excision margins for fibrohistiocytic tumors, including atypical fibroxanthoma and undifferentiated pleomorphic sarcoma: a probability model based on a systematic review","volume":"87","author":"Jibbe","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2024040918141071200_llad166-B6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1524-4725.2010.01843.x","article-title":"Atypical fibroxanthoma: a review of the literature","volume":"37","author":"Iorizzo","year":"2011","journal-title":"Dermatol Surg"},{"key":"2024040918141071200_llad166-B7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/PAS.0b013e31825359e1","article-title":"Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma","volume":"36","author":"Miller","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"2024040918141071200_llad166-B8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1684\/ejd.2020.3875","article-title":"Pleomorphic dermal sarcoma: a retrospective study of 16 cases in a dermato-oncology centre and a review of the literature","volume":"30","author":"R\u00edos-Vi\u00f1uela","year":"2020","journal-title":"Eur J Dermatol"},{"key":"2024040918141071200_llad166-B9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cup.12603","article-title":"Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated","volume":"43","author":"Tard\u00edo","year":"2016","journal-title":"J Cutan Pathol"},{"key":"2024040918141071200_llad166-B10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ad.2018.06.012","article-title":"Leiomyosarcoma and pleomorphic dermal sarcoma: guidelines for diagnosis and treatment","volume":"110","author":"Llombart","year":"2019","journal-title":"Actas DermoSifiliogr"},{"issue":"Suppl. S1","key":"2024040918141071200_llad166-B11","first-page":"114","article-title":"DS27: is a conservative approach to the surgical management of dermal leiomyosarcoma acceptable?","volume":"83","author":"Khan","year":"2020","journal-title":"Br J Dermatol"},{"key":"2024040918141071200_llad166-B12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/ajd.13307","article-title":"Cutaneous leiomyosarcoma: dermal and subcutaneous","volume":"61","author":"Wong","year":"2020","journal-title":"Australas J Dermatol"},{"key":"2024040918141071200_llad166-B13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1684\/ejd.2015.2681","article-title":"Primary cutaneous and subcutaneous leiomyosarcomas: evolution and prognostic factors","volume":"26","author":"Aneiros-Fernandez","year":"2016","journal-title":"Eur J Dermatol"},{"key":"2024040918141071200_llad166-B14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejso.2020.06.022","article-title":"Adequate surgical margins for dermatofibrosarcoma protuberans \u2013 a multi-centre analysis","volume":"47","author":"Huis","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2024040918141071200_llad166-B15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaad.2014.03.018","article-title":"A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change","volume":"71","author":"Liang","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2024040918141071200_llad166-B16","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.ejca.2015.06.108","article-title":"Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline","volume":"51","author":"Saiag","year":"2015","journal-title":"Eur J Cancer"},{"key":"2024040918141071200_llad166-B17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/CCO.0000000000000427","article-title":"Cutaneous angiosarcoma: update on biology and latest treatment","volume":"30","author":"Ishida","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"2024040918141071200_llad166-B18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fonc.2018.00046","article-title":"Cutaneous angiosarcoma: the possibility of new treatment options especially for patients with large primary tumor","volume":"8","author":"Fujisawa","year":"2018","journal-title":"Front Oncol"},{"key":"2024040918141071200_llad166-B19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ad.2018.06.013","article-title":"Kaposi sarcoma and cutaneous angiosarcoma: guidelines for diagnosis and treatment","volume":"109","author":"Requena","year":"2018","journal-title":"Actas DermoSifiliogr"},{"key":"2024040918141071200_llad166-B20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejca.2018.12.036","article-title":"Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF\/EADO\/EORTC)","volume":"114","author":"Lebbe","year":"2019","journal-title":"Eur J Cancer"},{"key":"2024040918141071200_llad166-B21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bjid.2014.01.002","article-title":"Consensus of the Brazilian Society of Infectious Diseases and Brazilian Society of Clinical Oncology on the management and treatment of Kaposi's sarcoma","volume":"18","author":"Arruda","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"2024040918141071200_llad166-B22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3332\/ecancer.2019.951","article-title":"Cancer prevention and control: Kaposi\u2019s sarcoma","volume":"13","author":"Orem","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"2024040918141071200_llad166-B23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.path.2017.01.008","article-title":"Cutaneous malignant peripheral nerve sheath tumor","volume":"10","author":"Luzar","year":"2017","journal-title":"Surg Pathol Clin"},{"key":"2024040918141071200_llad166-B24","doi-asserted-by":"crossref","first-page":"AB182","DOI":"10.1016\/j.jaad.2015.02.745","article-title":"Cutaneous malignant peripheral nerve sheath tumor: a clinical and histopathologic study of 17 cases","volume":"72","author":"Lowe","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2024040918141071200_llad166-B25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.anndiagpath.2013.10.007","article-title":"Malignant peripheral nerve sheath tumor: pathology and genetics","volume":"18","author":"Thway","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"2024040918141071200_llad166-B26","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/SAP.0000000000000465","article-title":"Superficial or cutaneous malignant peripheral nerve sheath tumor\u2014clinical experience at Taipei veterans general hospital","volume":"74","author":"Feng","year":"2015","journal-title":"Ann Plast Surg"},{"key":"2024040918141071200_llad166-B27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00000372-198906000-00004","article-title":"Malignant peripheral nerve sheath tumors of the skin","volume":"11","author":"George","year":"1989","journal-title":"Am J Dermatopathol"},{"key":"2024040918141071200_llad166-B28","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"Ducatman","year":"1986","journal-title":"Cancer"},{"key":"2024040918141071200_llad166-B29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/his.12756","article-title":"Cutaneous epithelioid malignant peripheral nerve sheath tumour: a clinicopathological analysis of 11 cases","volume":"68","author":"Luzar","year":"2016","journal-title":"Histopathology"},{"key":"2024040918141071200_llad166-B30","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/00000478-199112000-00004","article-title":"Epithelioid variant of malignant peripheral nerve sheath tumor (malignant epithelioid schwannoma)","volume":"15","author":"Laskin","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"2024040918141071200_llad166-B31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0025-6196(12)65011-3","article-title":"Neurofibrosarcoma of skin and subcutaneous tissues","volume":"65","author":"Dabski","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"2024040918141071200_llad166-B32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jaad.2014.07.020","article-title":"Leiomyosarcoma of the skin: clinical, histopathologic, and prognostic factors that influence outcomes","volume":"71","author":"Winchester","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2024040918141071200_llad166-B33","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1002\/cncr.24486","article-title":"Cluster analysis of immunohistochemical markers in leiomyosarcoma delineates specific anatomic and gender subgroups","volume":"115","author":"Carvalho","year":"2009","journal-title":"Cancer"},{"key":"2024040918141071200_llad166-B34","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.01408","article-title":"Identification of prognostic genes in leiomyosarcoma by gene co-expression network analysis","volume":"10","author":"Yang","year":"2020","journal-title":"Front Genet"},{"key":"2024040918141071200_llad166-B35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3892\/ol.2015.3966","article-title":"Clinicopathological features of dermatofibrosarcoma protuberans","volume":"11","author":"Larbcharoensub","year":"2016","journal-title":"Oncol Lett"},{"key":"2024040918141071200_llad166-B36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2559.2009.03310.x","article-title":"Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB) study with therapeutic implications","volume":"54","author":"Llombart","year":"2009","journal-title":"Histopathology"},{"key":"2024040918141071200_llad166-B37","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jclinpath-2017-204601","article-title":"Cutaneous angiosarcoma: a current update","volume":"70","author":"Shustef","year":"2017","journal-title":"J Clin Pathol"},{"key":"2024040918141071200_llad166-B38","article-title":"Angiosarcoma: a review of diagnosis and current treatment","volume":"9","author":"Cao","year":"2019","journal-title":"Am J Cancer Res"},{"key":"2024040918141071200_llad166-B39","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1245\/s10434-011-1978-7","article-title":"Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience","volume":"19","author":"Stucky","year":"2012","journal-title":"Ann Surgical Oncol"},{"key":"2024040918141071200_llad166-B40","volume-title":"McKee's Pathology of the Skin: With Clinical Correlations","author":"Calonje","year":"2012"},{"key":"2024040918141071200_llad166-B41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/PAS.0000000000000379","article-title":"Epithelioid malignant peripheral nerve sheath tumor","volume":"39","author":"Jo","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"2024040918141071200_llad166-B42","first-page":"425","article-title":"Malignant peripheral nerve sheath tumor: an immunohistochemical study of 62 cases","volume":"87","author":"Wick","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"2024040918141071200_llad166-B43","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1665977","article-title":"First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitors","volume":"8","author":"Klein","year":"2019","journal-title":"Oncoimmunology"},{"key":"2024040918141071200_llad166-B44","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1158\/1078-0432.CCR-20-1899","article-title":"Integrative analysis of pleomorphic dermal sarcomas reveals fibroblastic differentiation and susceptibility to immunotherapy integrative analysis of pleomorphic dermal sarcomas","volume":"26","author":"Klein","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2024040918141071200_llad166-B45","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/bjd.19346","article-title":"A 10-year review of surgical management of dermatofibrosarcoma protuberans","volume":"184","author":"Durack","year":"2021","journal-title":"Br J Dermatol"},{"key":"2024040918141071200_llad166-B46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0360-3016(97)00895-X","article-title":"The role of radiation therapy in the management of dermatofibrosarcoma protuberans","volume":"40","author":"Ballo","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024040918141071200_llad166-B47","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ejso.2017.03.011","article-title":"Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate \u2013 the impact of fibrosarcomatous transformation","volume":"43","author":"Rutkowski","year":"2017","journal-title":"Eur J Surg Oncol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad166\/50479176\/llad166.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/8\/866\/57192497\/llad166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/8\/866\/57192497\/llad166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T20:19:25Z","timestamp":1712693965000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/8\/866\/7147600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,5,2]]},"published-print":{"date-parts":[[2023,7,21]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad166","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,5,2]]}}}